These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7694127)

  • 1. Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes.
    Osmak M; Beketić-Oresković L; Matulić M; Sorić J
    Mutat Res; 1993 Nov; 303(3):113-20. PubMed ID: 7694127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple fractions of gamma rays do not induce overexpression of c-myc or c-Ki-ras oncogenes in human cervical carcinoma cells.
    Osmak M; Sorić J; Matulić M
    Neoplasma; 1993; 40(6):359-62. PubMed ID: 8289968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammineplatinum (II) or vincristine sulfate.
    Osmak M
    Neoplasma; 1992; 39(3):197-202. PubMed ID: 1528326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells.
    Osmak M; Bizjak L; Jernej B; Kapitanović S
    Mutat Res; 1995 Aug; 347(3-4):141-50. PubMed ID: 7565905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns.
    Beketić-Oresković L; Osmak M
    Neoplasma; 1994; 41(3):171-6. PubMed ID: 7935986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells.
    Beketic-Oreskovic L; Osmak M
    Cancer Chemother Pharmacol; 1995; 35(4):327-33. PubMed ID: 7828276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of myc overexpression on the phenotypic properties of Chinese hamster lung cells resistant to antitumor agents.
    Delaporte C; Larsen AK; Dautry F; Jacquemin-Sablon A
    Exp Cell Res; 1991 Dec; 197(2):176-82. PubMed ID: 1720389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
    Li DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
    Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
    Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
    Endlich B; Salavati R; Sullivan T; Ling CC
    Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
    Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of drug resistant-genes in cisplatin-resistant colon carcinoma cells by RT-PCR assay. II].
    Funato T; Tone T; Miyachi H; Ishimori A
    Rinsho Byori; 1993 Feb; 41(2):197-202. PubMed ID: 8361021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L; Osmak M; Jaksić M
    Neoplasma; 1994; 41(3):163-9. PubMed ID: 7935985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cisplatin treatment on early activation of oncogenes in vivo.
    Németh A; Gyöngyi Z; Nádasi E; Ember A; Olasz L; Nyárády Z; Skapinyecz J; Ember I
    In Vivo; 2002; 16(5):307-10. PubMed ID: 12494868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine.
    Osmak M
    Neoplasma; 1993; 40(2):97-101. PubMed ID: 8102478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
    Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
    Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.